380 related articles for article (PubMed ID: 9630405)
1. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
4. In-vitro microbiological assessment of a new penem, Men 10700.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1997 May; 39(5):575-84. PubMed ID: 9184355
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
[TBL] [Abstract][Full Text] [Related]
6. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
7. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of beta-lactam resistance in anaerobic bacteria.
Nord CE
Rev Infect Dis; 1986; 8 Suppl 5():S543-8. PubMed ID: 3541135
[TBL] [Abstract][Full Text] [Related]
9. Anaerobic bacteria and beta-lactam antibiotics.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
[TBL] [Abstract][Full Text] [Related]
10. The in-vitro activity of faropenem, a novel oral penem.
Woodcock JM; Andrews JM; Brenwald NP; Ashby JP; Wise R
J Antimicrob Chemother; 1997 Jan; 39(1):35-43. PubMed ID: 9044026
[TBL] [Abstract][Full Text] [Related]
11. Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
Nishino T; Maeda Y; Ohtsu E; Koizuka S; Nishihara T; Adachi H; Okamoto K; Ishiguro M
J Antibiot (Tokyo); 1989 Jun; 42(6):977-88. PubMed ID: 2661512
[TBL] [Abstract][Full Text] [Related]
12. Mode of action of beta-lactam antibiotics.
Tipper DJ
Pharmacol Ther; 1985; 27(1):1-35. PubMed ID: 3889939
[No Abstract] [Full Text] [Related]
13. Resistance to beta-lactam antibiotics in anaerobic bacteria.
Nord CE; Hedberg M
Rev Infect Dis; 1990; 12 Suppl 2():S231-4. PubMed ID: 2406875
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins.
Mett H; Schacher B; Schneider P; Zak O
Eur J Clin Microbiol; 1987 Dec; 6(6):674-8. PubMed ID: 3126060
[TBL] [Abstract][Full Text] [Related]
15. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
Neu HC
Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
[TBL] [Abstract][Full Text] [Related]
16. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
Nayler JH
J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
[No Abstract] [Full Text] [Related]
17. In vitro activity of cefodizime.
Knothe H; Shah PM
Infection; 1992; 20 Suppl 1():S3-8. PubMed ID: 1526673
[TBL] [Abstract][Full Text] [Related]
18. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Shannon K; King A; Phillips I
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
[TBL] [Abstract][Full Text] [Related]
19. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
Gunkel AG; Hechler U; Martin HH
J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]